12 June 2020 | Views
Arpan Malhotra, India Business Head - Diagnostics, Siemens Healthcare, Gurugram shares his thoughts on the ongoing COVID-19 situation
"Country is now moving towards a need for mass screening and community surveillance for COVID-19. Laboratory based antibody tests (CLIA) are not just higher in sensitivity, but are also scalable to very high throughputs. This can enable an increased expanse of COVID-19 testing to larger population via already available network of thousands of government and private facilities, that are equipped for this testing."
Arpan Malhotra, India Business Head - Diagnostics, Siemens Healthcare, Gurugram